Common TitleHPTN 083-1 (Adolescents)
Official Title Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males - A Sub-study of HPTN 083
Phase Phase II
ClinicalTrials.gov NCT04692077
Treatments
Cabotegravir
Cabotegravir
Tradename:ApretudeOther Names:Injectable cabotegravir, Long-acting injectable cabotegravirClass:Integrase Inhibitors (INSTI)Funding
IndustryViiV Healthcare
Non-IndustryNational Institute of Allergy and Infectious Diseases